Indication
Disease-modifying treatment of grass pollen induced rhinitis and conjunctivitis in adults and children (5 years or older), with clinically relevant symptoms and diagnosed with a positive skin prick test and/or specific IgE test to grass pollen.
Medicine details
- Medicine name:
- timothy grass pollen allergen (GRAZAX)
- SMC ID:
- SMC3017
- Pharmaceutical company
- ALK-Abello Ltd
- BNF chapter
- Respiratory system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC